PremiumCompany AnnouncementsHSBC to Issue US$1.5 Billion Perpetual Contingent Convertible Securities1d ago
PremiumThe FlyKennedy driving vast vaccine inquiry despite toned-down criticism, NYT says1d agoAZNBMY
PremiumRatingsAstraZeneca: Buy Rating Reiterated on De-Risked Pipeline, Attractive Valuation and Unchanged £165 Price Target2d agoAZN
AstraZeneca: Buy Rating Reiterated on De-Risked Pipeline, Attractive Valuation and Unchanged £165 Price Target